Global Anti-Obesity Prescription Market Research Report 2019

Table of Contents

Executive Summary

1 Anti-Obesity Prescription Market Overview

• 1.1 Product Overview and Scope of Anti-Obesity Prescription
• 1.2 Anti-Obesity Prescription Segment by Type
  • 1.2.1 Global Anti-Obesity Prescription Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Bupropion and Naltrexone
  • 1.2.3 Orlistat
  • 1.2.4 Lorcaserin
  • 1.2.5 Phentermine and Topiramate
  • 1.2.6 Liraglutide
• 1.3 Anti-Obesity Prescription Segment by Application
  • 1.3.1 Anti-Obesity Prescription Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 E-Commerce
• 1.4 Global Anti-Obesity Prescription Market by Region
  • 1.4.1 Global Anti-Obesity Prescription Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Anti-Obesity Prescription Market Size
  • 1.5.1 Global Anti-Obesity Prescription Revenue (2014-2025)
  • 1.5.2 Global Anti-Obesity Prescription Production (2014-2025)

2 Global Anti-Obesity Prescription Market Competition by Manufacturers

• 2.1 Global Anti-Obesity Prescription Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Anti-Obesity Prescription Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Anti-Obesity Prescription Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Anti-Obesity Prescription Production Sites, Area Served, Product Types
• 2.5 Anti-Obesity Prescription Market Competitive Situation and Trends
  • 2.5.1 Anti-Obesity Prescription Market Concentration Rate
  • 2.5.2 Anti-Obesity Prescription Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Obesity Prescription Production Market Share by Regions

• 3.1 Global Anti-Obesity Prescription Production Market Share by Regions
• 3.2 Global Anti-Obesity Prescription Revenue Market Share by Regions (2014-2019)
• 3.3 Global Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Anti-Obesity Prescription Production
  • 3.4.1 North America Anti-Obesity Prescription Production Growth Rate (2014-2019)
  • 3.4.2 North America Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Anti-Obesity Prescription Production
  • 3.5.1 Europe Anti-Obesity Prescription Production Growth Rate (2014-2019)
  • 3.5.2 Europe Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Anti-Obesity Prescription Production (2014-2019)
  • 3.6.1 China Anti-Obesity Prescription Production Growth Rate (2014-2019)
  • 3.6.2 China Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Anti-Obesity Prescription Production (2014-2019)
  • 3.7.1 Japan Anti-Obesity Prescription Production Growth Rate (2014-2019)
  • 3.7.2 Japan Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Anti-Obesity Prescription Consumption by Regions

• 4.1 Global Anti-Obesity Prescription Consumption by Regions
• 4.2 North America Anti-Obesity Prescription Consumption (2014-2019)
• 4.3 Europe Anti-Obesity Prescription Consumption (2014-2019)
• 4.4 China Anti-Obesity Prescription Consumption (2014-2019)
• 4.5 Japan Anti-Obesity Prescription Consumption (2014-2019)

5 Global Anti-Obesity Prescription Production, Revenue, Price Trend by Type

• 5.1 Global Anti-Obesity Prescription Production Market Share by Type (2014-2019)
• 5.2 Global Anti-Obesity Prescription Revenue Market Share by Type (2014-2019)
• 5.3 Global Anti-Obesity Prescription Price by Type (2014-2019)
• 5.4 Global Anti-Obesity Prescription Production Growth by Type (2014-2019)

6 Global Anti-Obesity Prescription Market Analysis by Applications

• 6.1 Global Anti-Obesity Prescription Consumption Market Share by Application (2014-2019)
• 6.2 Global Anti-Obesity Prescription Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Anti-Obesity Prescription Business

• 7.1 Zydus Cadila
  • 7.1.1 Zydus Cadila Anti-Obesity Prescription Production Sites and Area Served
  • 7.1.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.1.3 Zydus Cadila Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Akrimax Pharmaceuticals
  • 7.2.1 Akrimax Pharmaceuticals Anti-Obesity Prescription Production Sites and Area Served
  • 7.2.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.2.3 Akrimax Pharmaceuticals Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Zealand Pharma
  • 7.3.1 Zealand Pharma Anti-Obesity Prescription Production Sites and Area Served
  • 7.3.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.3.3 Zealand Pharma Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Arrowhead Research
  • 7.4.1 Arrowhead Research Anti-Obesity Prescription Production Sites and Area Served
  • 7.4.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.4.3 Arrowhead Research Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Arena Pharmaceuticals
  • 7.5.1 Arena Pharmaceuticals Anti-Obesity Prescription Production Sites and Area Served
  • 7.5.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.5.3 Arena Pharmaceuticals Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Compellis Pharmaceuticals
  • 7.6.1 Compellis Pharmaceuticals Anti-Obesity Prescription Production Sites and Area Served
  • 7.6.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.6.3 Compellis Pharmaceuticals Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Yungjin Pharm
  • 7.7.1 Yungjin Pharm Anti-Obesity Prescription Production Sites and Area Served
  • 7.7.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.7.3 Yungjin Pharm Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Alpex Pharma
  • 7.8.1 Alpex Pharma Anti-Obesity Prescription Production Sites and Area Served
  • 7.8.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.8.3 Alpex Pharma Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Bridge BioResearch
  • 7.9.1 Bridge BioResearch Anti-Obesity Prescription Production Sites and Area Served
  • 7.9.2 Anti-Obesity Prescription Product Introduction, Application and Specification
  • 7.9.3 Bridge BioResearch Anti-Obesity Prescription Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served

8 Anti-Obesity Prescription Manufacturing Cost Analysis

• 8.1 Anti-Obesity Prescription Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Anti-Obesity Prescription
• 8.4 Anti-Obesity Prescription Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Anti-Obesity Prescription Distributors List
• 9.3 Anti-Obesity Prescription Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Anti-Obesity Prescription Market Forecast

• 11.1 Global Anti-Obesity Prescription Production, Revenue Forecast
  • 11.1.1 Global Anti-Obesity Prescription Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Anti-Obesity Prescription Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Anti-Obesity Prescription Price and Trend Forecast (2019-2025)
• 11.2 Global Anti-Obesity Prescription Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Anti-Obesity Prescription Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Anti-Obesity Prescription Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Anti-Obesity Prescription Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Anti-Obesity Prescription Production, Revenue Forecast (2019-2025)
• 11.3 Global Anti-Obesity Prescription Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Anti-Obesity Prescription Consumption Forecast (2019-2025)
  • 11.3.2 Europe Anti-Obesity Prescription Consumption Forecast (2019-2025)
  • 11.3.3 China Anti-Obesity Prescription Consumption Forecast (2019-2025)
  • 11.3.4 Japan Anti-Obesity Prescription Consumption Forecast (2019-2025)
• 11.4 Global Anti-Obesity Prescription Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Anti-Obesity Prescription Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List